Leveraging Real World Data to Identify Pediatric Drug Safety Knowledge Gaps - Ep 172

About this episode

The episode discusses the efforts to address pediatric drug safety knowledge gaps, particularly focusing on the use of benzonatate in children.

Despite evidence that adverse drug events manifest with greater severity in pediatric populations than in adults, fewer than 50% of drugs have been systematically studied for pediatric use. The lack of robust drug safety data may result in suboptimal or harmful treatment strategies. Saurabh Rahurkar and Pallavi Jonnalagadda share their team's efforts to address this issue. This podcast and article specifically address the use of benzonatate in pediatric patients. Read the full text open access manuscript at: https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/phar.70061 .

People in this episode

Guests: Saurabh Rahurkar, Pallavi Jonnalagadda

Topics covered

• pediatric drug safety
• adverse drug events
• real world data

Keywords

• drug safety
• pediatrics
• benzonatate

Mentioned in this episode

Products: benzonatate

More episodes of ACCP JOURNALS

• Getting Published in JACCP: Tips for Success - Ep 184 · June 9, 2026 · 28 min
• Predicting Fall Risks in Older Adults with Depression: A Machine Learning Approach - Ep 183 · May 19, 2026 · 30 min
• Reimagining Renal Assessment: Pros and Cons - Ep 182 · May 12, 2026 · 38 min
• Navigating Cardiotoxicity in Modern Cancer Therapy - Ep 181 · April 22, 2026 · 33 min
• High-Value Interventions Primary Care Practices Might Be Overlooking: Clinical Pharmacy Services – Ep 180 · April 7, 2026 · 36 min
• Enhancing Pharmacotherapy Through Artificial Intelligence: From Prediction Models to Practice – Ep 179 · March 25, 2026 · 24 min